Overview
Polyarticular juvenile idiopathic arthritis (polyarticular JIA) is a type of childhood arthritis that affects five or more joints during the first six months of the disease. It is sometimes called polyarticular juvenile rheumatoid arthritis or polyarticular-onset JIA. This condition causes the immune system to mistakenly attack the lining of the joints, leading to inflammation, pain, swelling, and stiffness. It most commonly affects the small joints of the hands and feet, but can also involve the knees, hips, ankles, wrists, and neck. There are two subtypes of polyarticular JIA: rheumatoid factor (RF) positive and RF negative. The RF-positive form behaves more like adult rheumatoid arthritis and tends to be more aggressive. The RF-negative form is more common and may have a more variable course. Children with this condition may experience morning stiffness, fatigue, reduced appetite, and difficulty with everyday activities like writing, walking, or dressing. Treatment has improved significantly over the past two decades. The goal is to control inflammation, prevent joint damage, and help children live active lives. Treatment typically includes nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) like methotrexate, and biologic therapies such as etanercept, adalimumab, abatacept, and tocilizumab. With early and aggressive treatment, many children achieve remission or significant improvement in their symptoms.
Key symptoms:
Joint pain in five or more jointsJoint swelling and warmthMorning stiffness lasting more than 30 minutesDifficulty moving or bending jointsFatigue and low energyReduced appetite or poor weight gainLow-grade feverLimping or changes in walkingDifficulty with fine motor tasks like writing or buttoning clothesJoint stiffness after sitting or restingEye inflammation (uveitis)Growth problems or uneven limb lengthMuscle weakness around affected jointsIrritability in younger children
Multifactorial
Caused by a mix of several genes and environmental factors
Childhood
Begins in childhood, roughly ages 1 to 12
FDA & Trial Timeline
1 eventSIMPONI ARIA®: FDA approved
treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
5 availableEnbrel
indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older
Orencia
the treatment of patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA)
Actemra
indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older
HUMIRA
Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older
SIMPONI ARIA�
treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older
Clinical Trials
View all trials with filters →No actively recruiting trials found for Polyarticular juvenile idiopathic arthritis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
3 resourcesTravel Grants
No travel grants are currently matched to Polyarticular juvenile idiopathic arthritis.
Community
No community posts yet. Be the first to share your experience with Polyarticular juvenile idiopathic arthritis.
Start the conversation →Latest news about Polyarticular juvenile idiopathic arthritis
No recent news articles for Polyarticular juvenile idiopathic arthritis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is my child's polyarticular JIA rheumatoid factor positive or negative, and what does that mean for the long-term outlook?,What treatment plan do you recommend, and what are the potential side effects of these medications?,How often does my child need eye exams to check for uveitis?,What signs should I watch for that would indicate a disease flare or a medication side effect?,Are there any activities my child should avoid, or can they participate in sports and physical education?,What is the likelihood that my child will achieve remission, and could they eventually stop taking medications?,How will this condition be managed as my child grows into a teenager and young adult?
Common questions about Polyarticular juvenile idiopathic arthritis
What is Polyarticular juvenile idiopathic arthritis?
Polyarticular juvenile idiopathic arthritis (polyarticular JIA) is a type of childhood arthritis that affects five or more joints during the first six months of the disease. It is sometimes called polyarticular juvenile rheumatoid arthritis or polyarticular-onset JIA. This condition causes the immune system to mistakenly attack the lining of the joints, leading to inflammation, pain, swelling, and stiffness. It most commonly affects the small joints of the hands and feet, but can also involve the knees, hips, ankles, wrists, and neck. There are two subtypes of polyarticular JIA: rheumatoid fa
How is Polyarticular juvenile idiopathic arthritis inherited?
Polyarticular juvenile idiopathic arthritis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Polyarticular juvenile idiopathic arthritis typically begin?
Typical onset of Polyarticular juvenile idiopathic arthritis is childhood. Age of onset can vary across affected individuals.
Which specialists treat Polyarticular juvenile idiopathic arthritis?
10 specialists and care centers treating Polyarticular juvenile idiopathic arthritis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Polyarticular juvenile idiopathic arthritis?
3 patient support programs are currently tracked on UniteRare for Polyarticular juvenile idiopathic arthritis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.